aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Sio Capital Management is a New York-based investment management firm specializing in global healthcare-focused investments. The firm operates as a global equity market neutral healthcare hedge fund, aiming to generate attractive returns for its investors. Sio Capital typically engages in post-IPO equity rounds, leveraging its deep sector expertise to identify and capitalize on opportunities within the healthcare industry.
Founded by Dr. Michael Castor, Sio Capital Management is known for its rigorous investment philosophy, which emphasizes thorough knowledge of portfolio companies and a commitment to protecting and growing client assets. Notable portfolio companies include Onconova Therapeutics and X4 Pharmaceuticals. The firm offers unique value-add services by prioritizing clients' interests in every decision and maintaining a disciplined, research-driven approach to investment.
Also Known As
Sio Capital Management LLC
Operating Status
Active
Sio Capital Management Address
New York City,
New York
10017
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts